CAS RN: 85817-34-1
4-N-BENZYL-2-HYDROXYMETHYLPIPERAZINE
Product Availability
Choose a grade to view its available package options.
3 package records 1 with current stock 1 grade group
Grade
95% (3)
In stock only
Batch No. Package Availability Warehouse Inquiry
Batchno.20260519
1g
Out of stock
Inquiry
Batchno.20260312
250mg
In stock
Shenzhen Inquiry
Batchno.20250830
5g
Out of stock
Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 85817-34-1
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Shenzhen
Inquiry
85817-34-1 / (4-benzylpiperazin-2-yl)methanol
Standard CAS: 85817-34-1
Multi CAS: Yes
Basic Information
copy
CAS
85817-34-1 copy
Multi CAS
Yes copy
Molecular Formula
C12H18N2O copy
Molecular Weight
206.280000 copy
Exact Mass
206.141913 copy
InChI
InChI=1S/C12H18N2O/c15-10-12-9-14(7-6-13-12)8-11-4-2-1-3-5-11/h1-5,12-13,15H,6-10H2 copy
InChIKey
PJMFGDYBTJEEDP-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
15 copy
Aromatic heavy atom count
6 copy
Fraction Csp3
0.5 copy
Rotatable bonds
3 copy
H-bond acceptors
3 copy
H-bond donors
2 copy
Molar refractivity
60.6 copy
TPSA
35.5 copy
LogP / Solubility
WLOGP
0.45 copy
MLOGP
0.4 copy
XLogP3
0.5 copy
Consensus LogP
0.45 copy
Log S (ESOL)
-1.5 copy
Class (ESOL)
Soluble copy
Log S (Ali)
-1.58 copy
Class (Ali)
Soluble copy
Log S (SILICOS-IT)
-1.74 copy
Class (SILICOS-IT)
Soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-3.66 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
2 copy